KI-Beratung Beta

Produktbild: Immune Checkpoint Inhibitors in Cancer

Immune Checkpoint Inhibitors in Cancer

104,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune...

Beschreibung

Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research.

  • Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages
  • Helps you translate current research and literature into practical information for daily practice
  • Presents information logically organized by disease site
  • Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks
  • Consolidates today s available information on this timely topic into one convenient resource

Rezension

"Overall, this is an informative and authoritative book that includes experiences from clinicians and scientists working at some of the most renowned cancer centers in the world." -Ravi Salgia, MD, PhD (City of Hope) Doody's Score: 100-5 Stars!

Portrait

Dr. Fumito Ito is Associate Professor of Oncology, Department of Surgical Oncology and a member of the Center for Immunotherapy at Roswell Park Cancer Institute, as well as Associate Professor of Surgery at Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

22.08.2018

Herausgeber Fumito Ito + weitere
Verlag Elsevier Health Science

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

22.08.2018

Herausgeber
Verlag Elsevier Health Science
Seitenzahl

270

Maße (L/B/H)

23,6/19,1/1,7 cm

Gewicht

556 g

Sprache

Englisch

ISBN

978-0-323-54948-6

EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com

Herstelleradresse

Elsevier Health Science
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Ein neues Kapitel für Ihre Bücher

Ein neues Kapitel für Ihre Bücher

Schenken Sie Ihren alten Schätzen ein zweites Leben und erhalten Sie dafür eine Thalia Geschenkkarte.

Jetzt verkaufen
Jetzt verkaufen

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Immune Checkpoint Inhibitors in Cancer
  • 1. Tumor Immunology
    2. Melanoma and Other Skin Cancers
    3. Thoracic Malignancies
    4. Gastrointestinal, Hepatobiliary, and Pancreatic Malignancies
    5. Cancers of the Head and Neck
    6. Urologic Malignancies
    7. Gynecologic Malignancies
    8. Breast Cancer
    9. Hematologic Malignancies
    10. Pediatric Malignancies
    11. Toxicities Associated with Immune Checkpoint Inhibitors
    12. Future of Immune Checkpoint Inhibitors